Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?

Eur J Cancer. 1996 Sep;32A(10):1652-60. doi: 10.1016/0959-8049(96)00177-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use
  • Breast Neoplasms / drug therapy
  • Doxorubicin / administration & dosage*
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use
  • Drug Administration Schedule
  • Female
  • Heart Failure / chemically induced
  • Humans
  • Lung Neoplasms / drug therapy
  • Sarcoma / drug therapy

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin